Aubagio (teriflunomide)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) June 2016 CONTRAINDICATIONS (addition) Patients with a history of a hypersensitivity reaction to teriflunomide, leflunomide, or to...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts